Skip to main content

Table 3 Baseline and clinical characteristics of patients

From: Whole blood RNA sequencing reveals a differential transcriptomic profile associated with cervical insufficiency: a pilot study

  CI group (n = 25) Normal controls (n = 17) P value CI-term group (n = 8) CI-preterm group (n = 17) P value
Maternal age (years) 34.0 (31.0–37.0) 37.0 (31.5–38.0) 0.20 34.5 (32.3–37.0) 34.0 (30.5–36.5) 0.59
Nulliparous, n (%) 13 (52.0) 6 (35.3) 0.35 2 (25.0) 11 (64.7) 0.68
Gestational age at blood collection (weeks) 22.4 (18.5–25.0) 24.1 (18.0–24.5) 0.33 23.7 (22.3–25.2) 21.4 (19.1–23.8) 0.08
Gestational age at delivery (weeks) 26.4 (21.2–37.3) 38.1 (37.6–38.4) < 0.01 37.2 (37.0–37.5) 24.2 (20.8–26.9) < 0.01
Cervical dilation
 ≥ 3 cm 18 (72.0)   3 (37.5) 15 (88.2) 0.02
 < 3 cm 7 (28.0)   5 (62.5) 2 (11.8) 0.02
WBC count (cell/mL) 11,680 (9340-14,085)   8440 (8250-12,498) 12,970 (10,320-14,280) 0.01
Neutrophil count 9220 (6835-11,495)   6375 (5770-9765) 10,150 (7810-12,140) 0.01
C-reactive protein (mg/L) 5.0 (3.9–20.4)   4.0 (1.5–4.2) 7.9 (4.7–29.5) 0.01
  1. CI Cervical insufficiency